Epacadostat and Pembrolizumab in Treating Patients With Metastatic or Unresectable Gastroesophageal Junction or Gastric Cancer

Conditions:   Gastric Adenocarcinoma;   Gastroesophageal Junction Adenocarcinoma;   Recurrent Esophageal Carcinoma;   Recurrent Gastric Carcinoma;   Stage IV Esophageal Cancer AJCC v7;   Stage IV Gastric Cancer AJCC v7;   Unresectable Esophageal Carcinoma
Interventions:   Drug: Epacadostat;   Other: Laboratory Biomarker Analysis;   Biological: Pembrolizumab
Sponsor:   Pamela L. Kunz
Not yet recruiting - verified June 2017

http://ift.tt/2tyhDLd